Announcement on Company Name Change by Jiangsu Vcare Pharmatech Co., Ltd.
Published Time:
2024-07-19 17:44
Source:
July 12, 2024, Jiangsu Vcare Pharmatech Co., Ltd. (hereinafter referred to as "the Company") has completed the industrial and commercial registration for its name change and obtained the renewed Business License issued by the Administrative Approval Bureau of Nanjing Jiangbei New Area.
Chinese Name Update: The Chinese name now includes the term "股份（Gufen）" (Shareholding), formally adopting: 江苏威凯尔医药科技股份有限公司（Jiangsu weikaier yiyao keji gufen youxiangongsi）; Effective immediately.
English Name Unchanged: Remains "JIANGSU VCARE PHARMATECH CO., LTD."
Seals: All existing seals (company seal, contract seal, financial seal, invoice seal, and business-specific seals) shall cease to be valid from August 1, 2024.
Banking & Legal Continuity: Bank accounts, tax ID, address, and contact details remain unchanged. The business entity and legal relationships are unaffected. Contracts, agreements, and legal documents signed under the former name remain fully valid until expiration. Assets, liabilities, and obligations are lawfully inherited by the renamed entity.
The Company reaffirms that all existing business relationships, service commitments, and operational stability will be maintained without interruption.
We sincerely apologize for any inconvenience caused by this change. We extend our heartfelt gratitude for your longstanding trust and support and look forward to pioneering new milestones together.
Jiangsu Vcare Pharmatech Co., Ltd - Innovating for Healthier Futures.
Related News
27
2017
/
03
Vice Chairman of Political Consultative Conference of Wenzhou Ouhai District Visited Jiangsu Vcare
The delegation of Political Consultative Conference of Wenzhou Ouhai District, accompanied by vice chairman of Political Consultative Conference of Pukou Economic Development Zone visited Jiangsu Vcare Pharmaceutical Technology Co., Ltd. on the afternoon of March 27, 2017. Yongqiang Liu, the general manager of Jiangsu Vcare received the delegation. Mr. Liu introduced the company's development history and R&D progress. He focused on the progress of phase II clinical trials and the future market prospect of innovative drug Vicagrel. The delegation highly recognized Vcare's advanced equipment and facilities, harmonious human environment and comprehensive research and development capabilities.
View Details
14
2017
/
03
Jiangsu Vcare Held “Firefighting and First Aid” Training
Jiangsu Vcare invited Lei Wang, a special instructor of Nanjing Anqu Fire Education Center to give a “Firefighting and First Aid” course to new employees on March 14, 2017 and 26 new employees participated in the training. Mr. Wang collected a large number of fire cases and carefully analyzed the causes of these fires. He taught everyone how to deal with fires. His explanations made everyone fully aware of the importance and urgency of fire safety. At the same time, everyone had a better understanding of various fire extinguishers and their instructions.
View Details
Company Address:
No. 136, Huakang Road, Jiangbei New Area, Nanjing, P. R. China
Subsidiary NJVcare Website：
Scan to see
Copyright © JIANGSU VCARE PHARMATECH CO.,LTD.
Powerby：www.300.cn nanjing.300.cn